Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eficacy and Safety of Restricted Fluid Therapy in Transient Tachypnea of the Newborn: A Randomized Controlled Study

NCT07549945 is registered in ClinicalTrials.gov with Hitit University as lead sponsor.

NCT NCT07549945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07549945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eficacy and Safety of Restricted Fluid Therapy in Transient Tachypnea of the Newborn: A Randomized Controlled Study
Lead sponsor
Hitit University
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2021
Completion date
July 31, 2023
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fluid therapy, transient tachypnea of the newborn